Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-04, Stock:LLY, The news for the past five days is as follows:
2018-04-27: NEWS1: Lilly to Participate in Bank of America Merrill Lynch Health Care Conference.NEWS2: How Did BioMarin Pharmaceutical Perform in 1Q18?.NEWS3: Eli Lilly’s 1Q18 Earnings: Human Pharmaceutical Products Segment.NEWS4: Eli Lilly’s 1Q18 Earnings by Segment.NEWS5: Allergan’s 1Q18 Estimates: Expect Growth in Revenues.NEWS6: Eli Lilly’s 1Q18 Earnings and Revenue Growth.NEWS7: Analyst Recommendations for Novo Nordisk in April.NEWS8: How Is Novo Nordisk Positioned before 1Q18?.
2018-04-30: NEWS1: What Analysts Recommend for Pfizer ahead of 1Q18 Earnings.NEWS2: Eli Lilly’s 1Q18 Earnings: Neuroscience Products Portfolio.NEWS3: Why Analysts Expect Pfizer to See Revenue Growth in 1Q18.NEWS4: Eli Lilly’s 1Q18 Earnings: Oncology Products Portfolio.NEWS5: Eli Lilly’s 1Q18 Earnings: Cardiovascular Products Portfolio.NEWS6: Leena Gandhi, M.D., Ph.D., to Lead Lilly Oncology Immuno-Oncology Medical Development.
2018-05-01: NEWS1: Analysts’ Recommendations for Eli Lilly and Peers in April.NEWS2: Amid Mixed News on Earnings, Merck & Co., Inc. (MRK) Stock Remains Steady.NEWS3: Amid Mixed News on Earnings, Merck & Co., Inc. (MRK) Stock Remains Steady.NEWS4: Pfizer Reports 1Q18 Earnings and Revenue Growth.NEWS5: Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health.NEWS6: Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health.NEWS7: Eli Lilly’s Valuation after Its 1Q18 Earnings.NEWS8: Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Underserved Neighborhoods in Indianapolis.NEWS9: Eli Lilly’s 1Q18 Earnings: Elanco, the Animal Health Segment.NEWS10: Eli Lilly’s 1Q18 Earnings: New Products Portfolio.
2018-05-02: NEWS1: Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc..NEWS2: Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc..NEWS3: Comparing BMY’s and LLY’s Valuation.NEWS4: These Pharma Stocks Offer the Most Upside Potential.NEWS5: Humalog and Basaglar: Major Growth Drivers for Eli Lilly in 2018.NEWS6: Eli Lilly Could Report Robust Rise in Net Profit Margins in 2018.NEWS7: Eli Lilly Expected to Report a Modest Rise in Revenues in 2018.NEWS8: Analyst Recommendations for Eli Lilly after 1Q18 Earnings.
2018-05-03: NEWS1: Health Secretary Alex Azar: ‘Bold action is on the way’ for drug prices.NEWS2: United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q.NEWS3: United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q.NEWS4: Teva Stock Rises on Strong 1Q18 Results, Outlook Up.NEWS5: Olumiant: A Key Drug in Rheumatoid Arthritis Indications.NEWS6: Label Expansion May Boost Trulicity’s Revenues.NEWS7: Factors that Could Drive Trulicity’s Revenue Growth in 2018.

Answer: Rise